Percutaneous versus Transcutaneous Electrical Stimulation of the Posterior Tibial Nerve in Idiopathic Overactive Bladder Syndrome with Urinary Incontinence in Adults: A Systematic Review.
adult
overactive
percutaneous electric nerve stimulation
tibial nerve
transcutaneous electric nerve stimulation
urinary bladder
urinary incontinence
Journal
Healthcare (Basel, Switzerland)
ISSN: 2227-9032
Titre abrégé: Healthcare (Basel)
Pays: Switzerland
ID NLM: 101666525
Informations de publication
Date de publication:
13 Jul 2021
13 Jul 2021
Historique:
received:
06
06
2021
revised:
08
07
2021
accepted:
11
07
2021
entrez:
6
8
2021
pubmed:
7
8
2021
medline:
7
8
2021
Statut:
epublish
Résumé
Percutaneous electrical stimulation and transcutaneous electrical stimulation (PTNS and TTNS) of the posterior tibial nerve are internationally recognized treatment methods that offer advantages in terms of treating patients with overactive bladder (OAB) who present with urinary incontinence (UI). This article aims to analyze the scientific evidence for the treatment of OAB with UI in adults using PTNS versus TTNS procedures in the posterior tibial nerve. A systematic review was conducted, between February and May 2021 in the Web of Science and Scopus databases, in accordance with the PRISMA recommendations. The research identified 259 studies, 130 of which were selected and analyzed, with only 19 used according to the inclusion requirements established. The greatest effectiveness, in reducing UI and in other parameters of daily voiding and quality of life, was obtained by combining both techniques with other treatments, pharmacological treatments, or exercise. TTNS has advantages over PTNS as it is more comfortable for the patient even though there is equality of both therapies in the outcome variables. More research studies are necessary in order to obtain clear scientific evidence.
Sections du résumé
BACKGROUND
BACKGROUND
Percutaneous electrical stimulation and transcutaneous electrical stimulation (PTNS and TTNS) of the posterior tibial nerve are internationally recognized treatment methods that offer advantages in terms of treating patients with overactive bladder (OAB) who present with urinary incontinence (UI). This article aims to analyze the scientific evidence for the treatment of OAB with UI in adults using PTNS versus TTNS procedures in the posterior tibial nerve.
METHODS
METHODS
A systematic review was conducted, between February and May 2021 in the Web of Science and Scopus databases, in accordance with the PRISMA recommendations.
RESULTS
RESULTS
The research identified 259 studies, 130 of which were selected and analyzed, with only 19 used according to the inclusion requirements established. The greatest effectiveness, in reducing UI and in other parameters of daily voiding and quality of life, was obtained by combining both techniques with other treatments, pharmacological treatments, or exercise.
CONCLUSIONS
CONCLUSIONS
TTNS has advantages over PTNS as it is more comfortable for the patient even though there is equality of both therapies in the outcome variables. More research studies are necessary in order to obtain clear scientific evidence.
Identifiants
pubmed: 34356261
pii: healthcare9070879
doi: 10.3390/healthcare9070879
pmc: PMC8306496
pii:
doi:
Types de publication
Journal Article
Review
Langues
eng
Références
Eur J Obstet Gynecol Reprod Biol. 2020 Jul;250:203-208
pubmed: 32464435
Int Urogynecol J. 2020 Dec;31(12):2457-2471
pubmed: 32681345
Neurourol Urodyn. 2018 Feb;37(2):528-541
pubmed: 28731583
Arab J Urol. 2019 Apr 08;17(1):10-13
pubmed: 31258940
Neurourol Urodyn. 2018 Feb;37(2):842-848
pubmed: 28792105
Neurourol Urodyn. 2019 Jan;38(1):261-268
pubmed: 30311692
BMC Health Serv Res. 2014 Nov 21;14:579
pubmed: 25413154
BJU Int. 2019 May;123(5A):E20-E28
pubmed: 30552801
Acta Med Indones. 2015 Jul;47(3):188-200
pubmed: 26586384
Eur J Obstet Gynecol Reprod Biol. 2015 Aug;191:51-6
pubmed: 26073262
Transl Androl Urol. 2018 Dec;7(6):912-919
pubmed: 30505727
Actas Urol Esp (Engl Ed). 2021 Apr;45(3):177-187
pubmed: 33353738
Clin Auton Res. 2020 Feb;30(1):61-67
pubmed: 30074101
World J Urol. 2018 Sep;36(9):1455-1460
pubmed: 29633085
Phys Ther. 2003 Aug;83(8):713-21
pubmed: 12882612
Actas Urol Esp. 2016 Apr;40(3):173-82
pubmed: 26811022
Actas Urol Esp. 2017 Sep;41(7):465-470
pubmed: 28325529
Eur Urol. 2014 Jan;65(1):79-95
pubmed: 24007713
Int Braz J Urol. 2017 Jan-Feb;43(1):121-126
pubmed: 28124534
Physiotherapy. 2019 Dec;105(4):469-475
pubmed: 30862384
Mayo Clin Proc. 2020 Feb;95(2):370-377
pubmed: 32029089
Urology. 2019 Sep;131:77-82
pubmed: 31199966
Toxins (Basel). 2020 Feb 18;12(2):
pubmed: 32085542
J Urol. 2013 Jun;189(6):2194-201
pubmed: 23219541
Eur Urol Focus. 2018 Jan;4(1):49-53
pubmed: 29773501
PLoS Med. 2007 Oct 16;4(10):e297
pubmed: 17941715
Can Urol Assoc J. 2020 Jul;14(7):E297-E303
pubmed: 32017693